Manufacturers Life Insurance Company, The Imago Bio Sciences, Inc. Transaction History

Manufacturers Life Insurance Company, The

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	N/A	-10,270 Closed	0 $0
Q4 2022 Aug 11, 2023	SELL	$15.03 - $35.96 $657,096 - $1.57 Million	-43,719 Reduced 80.98%	10,270 $369,000
Q4 2022 Feb 13, 2023	SELL	$15.03 - $35.96 $657,096 - $1.57 Million	-43,719 Reduced 80.98%	10,270 $369,000
Q3 2022 Aug 11, 2023	SELL	$14.15 - $19.5 $5,136 - $7,078	-363 Reduced 0.67%	53,989 $812,000
Q3 2022 Nov 03, 2022	SELL	$14.15 - $19.5 $5,136 - $7,078	-363 Reduced 0.67%	53,989 $823,000
Q2 2022 Aug 11, 2023	BUY	$11.81 - $20.92 $128,362 - $227,379	10,869 Added 25.0%	54,352 $727,000
Q2 2022 Aug 15, 2022	BUY	$11.81 - $20.92 $128,362 - $227,379	10,869 Added 25.0%	54,352 $690,000
Q1 2022 Aug 11, 2023	BUY	$16.97 - $25.0 $737,906 - $1.09 Million	43,483 New	43,483 $837,000
Q1 2022 May 20, 2022	BUY	$16.97 - $25.0 $737,906 - $1.09 Million	43,483 New	43,483 $915,000

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.